Characterization of posttranslational formylglycine formation by luminal components of the endoplasmic reticulum

Fey J, Balleininger M, Borissenko LV, Schmidt B, Figura von K, Dierks T (2001)
JOURNAL OF BIOLOGICAL CHEMISTRY 276(50): 47021-47028.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Fey, J; Balleininger, M; Borissenko, LV; Schmidt, B; Figura von, K; Dierks, ThomasUniBi
Abstract / Bemerkung
C-alpha-formylglycine is the key catalytic residue in the active site of sulfatases. In eukaryotes formylglycine is generated during or immediately after sulfatase translocation into the endoplasmic reticulum by oxidation of a specific cysteine residue. We established an in vitro assay that allowed us to measure formylglycine modification independent of protein translocation. The modifying enzyme was recovered in a microsomal detergent extract. As a substrate we used ribosome-associated nascent chain complexes comprising in vitro synthesized sulfatase fragments that were released from the ribosomes by puromycin. Formylglycine modification was highly efficient and did not require a signal sequence in the substrate polypeptide. Ribosome association helped to maintain the modification competence of nascent chains but only after their release efficient modification occurred. The modifying machinery consists of soluble components of the endoplasmic reticulum lumen, as shown by differential extraction of microsomes. The in vitro assay can be performed under kinetically controlled conditions. The activation energy for formylglycine formation is 61 kJ/mol, and the pH optimum is approximate to 10. The activity is sensitive to the SH/SS equilibrium and is stimulated by Ca2+. Formylglycine formation is efficiently inhibited by a synthetic sulfatase peptide representing the sequence directing formylglycine modification. The established assay system should make possible the biochemical identification of the modifying enzyme.
Erscheinungsjahr
2001
Zeitschriftentitel
JOURNAL OF BIOLOGICAL CHEMISTRY
Band
276
Ausgabe
50
Seite(n)
47021-47028
ISSN
0021-9258
eISSN
1083-351X
Page URI
https://pub.uni-bielefeld.de/record/2350792

Zitieren

Fey J, Balleininger M, Borissenko LV, Schmidt B, Figura von K, Dierks T. Characterization of posttranslational formylglycine formation by luminal components of the endoplasmic reticulum. JOURNAL OF BIOLOGICAL CHEMISTRY. 2001;276(50):47021-47028.
Fey, J., Balleininger, M., Borissenko, L. V., Schmidt, B., Figura von, K., & Dierks, T. (2001). Characterization of posttranslational formylglycine formation by luminal components of the endoplasmic reticulum. JOURNAL OF BIOLOGICAL CHEMISTRY, 276(50), 47021-47028. https://doi.org/10.1074/jbc.M108943200
Fey, J, Balleininger, M, Borissenko, LV, Schmidt, B, Figura von, K, and Dierks, Thomas. 2001. “Characterization of posttranslational formylglycine formation by luminal components of the endoplasmic reticulum”. JOURNAL OF BIOLOGICAL CHEMISTRY 276 (50): 47021-47028.
Fey, J., Balleininger, M., Borissenko, L. V., Schmidt, B., Figura von, K., and Dierks, T. (2001). Characterization of posttranslational formylglycine formation by luminal components of the endoplasmic reticulum. JOURNAL OF BIOLOGICAL CHEMISTRY 276, 47021-47028.
Fey, J., et al., 2001. Characterization of posttranslational formylglycine formation by luminal components of the endoplasmic reticulum. JOURNAL OF BIOLOGICAL CHEMISTRY, 276(50), p 47021-47028.
J. Fey, et al., “Characterization of posttranslational formylglycine formation by luminal components of the endoplasmic reticulum”, JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, 2001, pp. 47021-47028.
Fey, J., Balleininger, M., Borissenko, L.V., Schmidt, B., Figura von, K., Dierks, T.: Characterization of posttranslational formylglycine formation by luminal components of the endoplasmic reticulum. JOURNAL OF BIOLOGICAL CHEMISTRY. 276, 47021-47028 (2001).
Fey, J, Balleininger, M, Borissenko, LV, Schmidt, B, Figura von, K, and Dierks, Thomas. “Characterization of posttranslational formylglycine formation by luminal components of the endoplasmic reticulum”. JOURNAL OF BIOLOGICAL CHEMISTRY 276.50 (2001): 47021-47028.

19 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Eukaryotic formylglycine-generating enzyme catalyses a monooxygenase type of reaction.
Peng J, Alam S, Radhakrishnan K, Mariappan M, Rudolph MG, May C, Dierks T, von Figura K, Schmidt B., FEBS J 282(17), 2015
PMID: 26077311
Proprotein convertases process and thereby inactivate formylglycine-generating enzyme.
Ennemann EC, Radhakrishnan K, Mariappan M, Wachs M, Pringle TH, Schmidt B, Dierks T., J Biol Chem 288(8), 2013
PMID: 23288839
SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency.
Schlotawa L, Ennemann EC, Radhakrishnan K, Schmidt B, Chakrapani A, Christen HJ, Moser H, Steinmann B, Dierks T, Gärtner J., Eur J Hum Genet 19(3), 2011
PMID: 21224894
Murine model (Galns(tm(C76S)slu)) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins.
Tomatsu S, Vogler C, Montaño AM, Gutierrez M, Oikawa H, Dung VC, Orii T, Noguchi A, Sly WS., Mol Genet Metab 91(3), 2007
PMID: 17498992
A general binding mechanism for all human sulfatases by the formylglycine-generating enzyme.
Roeser D, Preusser-Kunze A, Schmidt B, Gasow K, Wittmann JG, Dierks T, von Figura K, Rudolph MG., Proc Natl Acad Sci U S A 103(1), 2006
PMID: 16368756
Sulfatases and human disease.
Diez-Roux G, Ballabio A., Annu Rev Genomics Hum Genet 6(), 2005
PMID: 16124866
Molecular basis for multiple sulfatase deficiency and mechanism for formylglycine generation of the human formylglycine-generating enzyme.
Dierks T, Dickmanns A, Preusser-Kunze A, Schmidt B, Mariappan M, von Figura K, Ficner R, Rudolph MG., Cell 121(4), 2005
PMID: 15907468
Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase.
Tomatsu S, Gutierrez M, Nishioka T, Yamada M, Yamada M, Tosaka Y, Grubb JH, Montaño AM, Vieira MB, Trandafirescu GG, Peña OM, Yamaguchi S, Orii KO, Orii T, Noguchi A, Laybauer L., Hum Mol Genet 14(22), 2005
PMID: 16219627
Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility.
Hanson SR, Best MD, Wong CH., Angew Chem Int Ed Engl 43(43), 2004
PMID: 15493058
Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme.
Dierks T, Schmidt B, Borissenko LV, Peng J, Preusser A, Mariappan M, von Figura K., Cell 113(4), 2003
PMID: 12757705
The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases.
Cosma MP, Pepe S, Annunziata I, Newbold RF, Grompe M, Parenti G, Ballabio A., Cell 113(4), 2003
PMID: 12757706

References

Daten bereitgestellt von Europe PubMed Central.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 11600503
PubMed | Europe PMC

Suchen in

Google Scholar